Have you ever looked at your family tree and noticed a pattern? Maybe an aunt with breast cancer, a grandparent with diabetes, or siblings with asthma and wondered, “Am I next?” Whether it is a chronic illness or a rare condition, many of us raise questions about whether our DNA is quietly deciding our future. This question sits at the intersection of science and personal experience. Can you inherit diseases? And if so, how much power do your genes really have over your health?
Thanks to breakthroughs in genomics, researchers are beginning to untangle the mystery. We now know that while some diseases are clearly passed from one generation to the next through single-gene mutations, others arise from a complex interplay of multiple genes and genetic variants shaped by biological and environmental factors.
This blog dives into the science of inherited diseases. It will break down how inheritance works, and what knowing your genetic background can (and cannot) tell you.
To understand how diseases are inherited, we need to start with what genes are.
Genes are segments of DNA that carry instructions for building and supporting your body. These genes are packaged into chromosomes, and you inherit one set of chromosomes from each parent.
So, how can I inherit a disease? Occasionally, genes can be damaged (mutations) and disrupt their function, potentially leading to disease.
It is important to note that not all mutations will lead to diseases; however, most diseases require a combination of genetic and environmental factors to manifest.
Can mutations in a single gene cause a mutation? Yes, they are known as monogenic disorders and follow predictable inheritance patterns. The four most common modes of inheritance are autosomal recessive, autosomal dominant, X-linked and mitochondrial inheritance.
Autosomal Recessive Inheritance
In autosomal recessive diseases, a person must inherit two copies of the mutated gene (one from each parent) to develop the disease. Individuals with only one mutated copy are carriers but usually do not show symptoms.
For instance:
- Cystic fibrosis, which affects the lungs and digestive system due to a defect in the CFTR gene
- Sickle cell anemia, a blood disorder characterized by abnormally shaped red blood cells caused by mutations in the HBB gene
What is the probability?
If both parents are carriers, there is a 25 per cent chance their child will inherit the disease, a 50 per cent chance of being a carrier, and a 25 per cent chance of inheriting healthy copies.
Autosomal Dominant Inheritance
Here, just one copy of the mutated gene is sufficient to cause the disease. However, not all individuals who inherit the mutation will develop symptoms, a phenomenon known as incomplete penetrance.
For example:
Huntington’s disease is a progressive neurodegenerative disorder with symptoms typically appearing in adulthood
Marfan syndrome affects connective tissue and often leads to cardiovascular and skeletal issues.
What is the probability?
Each child of an affected parent has a 50% chance of inheriting the mutation. There are no carriers of the mutation, and there is a 50% probability that the child will be healthy.
X-linked inheritance
Some disorders are inherited via sex chromosomes (X and Y) (e.g., hemophilia). Around 5- 10 % of Mendelian disorders are X-linked, but less than 1% are Y-linked. That’s why we will focus on explaining X-linked inheritance.
The X-linked inheritance can also be recessive and dominant; however, it differs from both autosomal recessive and autosomal dominant inheritance. Considering that women have two X chromosomes and men have one X chromosome. The parents and the sex of the baby will determine the presence of the disease.
1. Recessive X-linked inheritance
In this scenario, one of the X chromosomes carries the mutation. It’s important to note that women have two X chromosomes, allowing them to often serve as carriers of the mutation without showing any symptoms of the disease. It is because the second X chromosome can compensate for the affected one, effectively masking the effects of the disorder. As a result, women typically do not experience the full impact of the mutation. At the same time, men, who have only one X chromosome, are at a higher risk of developing symptoms when their single X carries the mutation.
What is the probability?
We are going to have two cases: Mother is a carrier, and father is healthy (case 1), mother is healthy, and father is affected (case 2)
Case 1 (mother is a carrier and the father is healthy)
There is a 50% chance that the baby will be male and a 50% chance that the baby will be female.
If the baby is male, he has a 50% chance of being male and a 25% chance of being affected by the condition. Since he has only one X chromosome, he will express the mutation if that chromosome carries it.
If the baby is female, there is a 50% chance of her being female. Among these girls, there’s a 25% chance that she will be healthy, and a 25% chance that she will be a carrier of the mutation. Since females have two X chromosomes, one can potentially compensate for the other.
Case 2 (mother is healthy and the father is sick)
In this scenario, there is a 50% chance that the baby will be male and a 50% chance that the baby will be female.
If the offspring is male, the father will pass on a Y chromosome, indicating that the male will be healthy. However, it’s important to note that there is still a 50% chance that the baby will be male.
If the child is female, the father must pass on his defective gene, which means that every daughter will be a carrier of the condition. However, there is a 50% chance of having a female child.
2. Dominant X-linked inheritance
Here, having just one damaged X chromosome is enough to have the disease. It doesn’t matter if the women have two X chromosomes.
What is the probability?
We will consider one case: the mother has the disease, while the father is healthy. In this situation, there is a 50% chance that the baby will be male and a 50% chance that the baby will be female.
If the baby is male, there is a 50% chance of him being healthy and a 25% chance of him being affected by the disease, since he has only one X chromosome. This pattern is similar to recessive X-linked inheritance.
If the baby is female, there is also a 50% chance of her being female. Among these females, there is a 25% chance that she will be healthy and a 25% chance that she will have the disease. In contrast to recessive X-linked disorders, damage to just one X chromosome can lead to disease in this case.
Mitochondrial inheritance
Mitochondrial inheritance refers to the transmission of mitochondrial DNA, which is inherited exclusively from the mother.
Suppose the mother is affected by a mitochondrial condition. In that case, all of her children will inherit the disease, resulting in a 100% likelihood of passing on the condition.
Most common diseases, such as type 2 diabetes, heart disease, asthma, Parkinson’s Alzheimer’s, and many cancers, do not follow simple Mendelian patterns.
These diseases are influenced by multiple genetic variants, often hundreds or thousands, with each contributing a small amount to overall risk (called polygenic inheritance).
But genetics alone does not decide outcomes. Environmental factors such as smoking or diet, lifestyle choices like exercise, and random biological events also affect disease development.
For example, type 2 diabetes risk is increased by inherited variants affecting insulin production and glucose metabolism, but lifestyle factors like obesity and physical inactivity play crucial roles in triggering the disease.
Can you inherit diseases? Yes. Some diseases follow clear genetic rules, especially single-gene disorders. However, many common illnesses are complex, influenced by multiple genes interacting with the environment and lifestyle.
Your genes provide a blueprint, but they are just one piece of the puzzle. Environmental exposures, diet, activity, stress, and chance play crucial roles. Thus, two people with the same genetic risk can have very different health outcomes. Understanding your genetic risk with balance and perspective can help you take charge of your health and reduce the impact of inherited diseases.
References
Bates, G.P., Dorsey, R., Gusella, J.F., Hayden, M.R., Kay, C., Leavitt, B.R., Nance, M., Ross, C.A., Scahill, R.I., Wetzel, R. and Wild, E.J., 2015. Huntington disease. Nature Reviews Disease Primers, 1(1), pp.1–21. https://doi.org/10.1038/nrdp.2015.5
Chatterjee, N., Shi, J. and García-Closas, M., 2016. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nature Reviews Genetics, 17(7), pp.392–406. https://doi.org/10.1038/nrg.2016.27
Cooper, D.N., Krawczak, M., Polychronakos, C., Tyler-Smith, C. and Kehrer-Sawatzki, H., 2013. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Human Genetics, 132(10), pp.1077–1130. https://doi.org/10.1007/s00439-013-1331-2
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A., 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 261(5123), pp.921–923. https://doi.org/10.1126/science.8346443
Dietz, H.C., 2019. Marfan syndrome. In: GeneReviews® [online]. Seattle: University of Washington. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1335/ [Accessed 19 July 2025].
Florez, J.C., 2008. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?. Diabetologia, 51(7), pp.1100–1110. https://doi.org/10.1007/s00125-008-0993-x
Karczewski, K.J., Francioli, L.C., Tiao, G. et al., 2020. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 581(7809), pp.434–443. https://doi.org/10.1038/s41586-020-2308-7
Khoury, M.J., Feero, W.G. and Chambers, D.A., 2010. Genetics and genomics and the prevention and treatment of disease: role of the basic sciences in clinical and public health practice. Translational Research, 154(6), pp.302–308. https://doi.org/10.1016/j.trsl.2010.09.001
Kuchenbaecker, K.B., Hopper, J.L., Barnes, D.R., et al., 2017. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 317(23), pp.2402–2416. https://doi.org/10.1001/jama.2017.7112
Lewis, C.M. and Vassos, E., 2020. Polygenic risk scores: from research tools to clinical instruments. Genome Medicine, 12(1), pp.1–11. https://doi.org/10.1186/s13073-020-00742-5
Lubs, H.A., Stevenson, R.E. and Schwartz, C.E., 2011. Fragile X and X-linked intellectual disability: four decades of discovery. American Journal of Human Genetics, 90(4), pp.579–590. https://doi.org/10.1016/j.ajhg.2012.03.002
Manolio, T.A., Collins, F.S., Cox, N.J., et al., 2009. Finding the missing heritability of complex diseases. Nature, 461(7265), pp.747–753. https://doi.org/10.1038/nature08494
Online Mendelian Inheritance in Man (OMIM), n.d. A catalog of human genes and genetic disorders. [online] Available at: https://www.omim.org/ [Accessed 19 July 2025].
Ratjen, F. and Döring, G., 2003. Cystic fibrosis. The Lancet, 361(9358), pp.681–689. https://doi.org/10.1016/S0140-6736(03)12567-6
Rees, D.C., Williams, T.N. and Gladwin, M.T., 2010. Sickle-cell disease. The Lancet, 376(9757), pp.2018–2031. https://doi.org/10.1016/S0140-6736(10)61029-X
Risch, N., 2018. How understanding genetic inheritance informs risk and prevention. Annual Review of Medicine, 69, pp.1–16. https://doi.org/10.1146/annurev-med-050216-030123
Scheuner, M.T., Wang, S.J., Raffel, L.J., Larabell, S.K. and Rotter, J.I., 1997. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. American Journal of Medical Genetics, 71(3), pp.315–324. https://doi.org/10.1002/(SICI)1096-8628(19970725)71:3<315::AID-AJMG19>3.0.CO;2-B
Schrijver, I., Aziz, N., Farkas, D.H., et al., 2018. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. The Journal of Molecular Diagnostics, 20(2), pp.129–140. https://doi.org/10.1016/j.jmoldx.2017.11.003
Visscher, P.M., Wray, N.R., Zhang, Q. et al., 2017. 10 years of GWAS discovery: biology, function, and translation. The American Journal of Human Genetics, 101(1), pp.5–22. https://doi.org/10.1016/j.ajhg.2017.06.005
Wallace, D.C., 1999. Mitochondrial diseases in man and mouse. Science, 283(5407), pp.1482–1488. https://doi.org/10.1126/science.283.5407.1482
Wu, Y., Zhai, L., Zhang, D., et al., 2018. Association of obesity and insulin resistance with risk of type 2 diabetes: a meta-analysis of prospective cohort studies. BMJ Open Diabetes Research and Care, 6(1), e000512. https://doi.org/10.1136/bmjdrc-2018-000512